Spline regression in clinical research.

Area of Science:

• Clinical research methodology
• Biostatistics
• Epidemiology

Background:

• Serum albumin levels are associated with patient outcomes.
• Traditional statistical methods may oversimplify complex dose-response relationships.
• Spline regression is an under-utilized statistical tool in clinical research.

Purpose of the Study:

• To illustrate the application and benefits of spline regression in clinical research.
• To assess the dose-response association between serum albumin and hospital mortality using spline regression.

Main Methods:

• Utilized data from a cohort of 117 patients hospitalized with invasive group A streptococcal disease.
• Compared a traditional categorical analysis of serum albumin (SA) with a quadratic spline regression model.
• Assessed the association between admission serum albumin levels and unadjusted hospital mortality.

Main Results:

• Categorical analysis showed mortality rates of 40.7% (< 2.5 g/dL), 14.8% (2.5-3.4 g/dL), and 8.3% (≥ 3.5 g/dL).
• Spline regression generated a smooth curve, providing a more nuanced and clinically plausible representation of the dose-response relationship.
• The spline model avoids the assumption of uniform risk within arbitrary categories.

Conclusions:

• Spline regression provides a more flexible and realistic approach to analyzing continuous risk factors like serum albumin.
• It overcomes limitations of categorical analysis, such as imposing homogeneity within groups and allowing abrupt risk changes between categories.
• Clinicians should consider spline regression for a more accurate assessment of dose-response associations in research.